Drreddys Laboratories reported INR817M in Interest Expense on Debt for its fiscal quarter ending in December of 2024.


Interest Expense On Debt Change Date
ANI Pharmaceuticals USD 5.44M 46K Jun/2025
Aurora Cannabis CAD 1.78M 491K Jun/2025
Bayer 495M 89M Jun/2025
Canopy Growth CAD 9.74M 7.03M Jun/2025
Cipla 140.5M 300K Jun/2025
Corcept Therapeutics 6M 6M Jun/2024
Drreddys Laboratories INR 817M 60M Dec/2024
GlaxoSmithKline 184M 22M Jun/2025
Hikma Pharmaceutical 22M 9M Jun/2024
Lonza CHF 70M 11M Dec/2024
Novartis USD 289M 19M Jun/2025
Pacira USD 3.82M 110K Jun/2025
Prestige Brands USD 10.2M 275K Jun/2025
Richter Gedeon HUF 7.5B 9.53B Sep/2024
Sun Pharmaceuticals 748M 256.6M Jun/2025
Supernus Pharmaceuticals USD 0 0 Dec/2024
Teva Pharmaceutical Industries USD 252M 40M Jun/2025